business

Explore

Longeveron Inc. Reports $22.7M 2025 Net Loss, HLHS Trial on Track

Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech firm focused on stem cell therapies for rare pediatric and aging-related diseases, disclosed…

CRBU Stock Trades Near Cash Despite Top Allogeneic CAR-T Data

Caribou Biosciences (CRBU) presents the most compelling data yet in the allogeneic CAR-T therapy field, where efficacy and safety metrics…

3 Stocks to Buy Aggressively with Fresh Capital Now

Investors often ask which stocks stand out in the current market. This question arises frequently, particularly given the daily focus…

Middle East Oil Output Drops 12M boe/d After Strait Closure

Middle East oil production has sharply declined by more than 12 million barrels of oil equivalent per day (boe/day) following…